EchoIQ Ltd
Echo IQ Secures Mayo Clinic Collaboration to Assess Cardiac Risk in Cancer Patients
Echo IQ teams with Mayo Clinic Arizona to test AI-driven cardiac risk scores from echocardiography in cancer patients; results expected 2027.
Echo IQ Expands Agreement with Mayo Clinic for Distribution of EchoSolv HF
Echo IQ expands Mayo Clinic distribution for EchoSolv HF; FDA clearance pending, auto-renew 3 years, unlocking Mayo Clinic Platform (MCP) network.
Echo IQ Reports Strong US Performance of EchoSolv AS Platform Ahead of Regulatory Clearance
Perth-based medical technology company Echo IQ (ASX: EIQ) has reported strong operational momentum from its EchoSolv AS platform in the US market, with a 153% increase in echocardiograms over the three months to September. The performance has come about through extensive engagement with US hospital groups, which have integrated the technology into their operations, resulting in the […]
Echo IQ Secures Echosolv Reseller Agreement with SARC MedIQ to Broaden US Uptake
Echo IQ (ASX: EIQ) will expand the use of its EchoSolv AI software through a US network of hospitals and cardiology practices after locking in a reseller agreement with provider SARC MedIQ. Under the terms, EchoSolv will be utilised by more than 1,500 physicians at over 300 healthcare facilities and clinics within SARC’s network in […]